Geneva (GNP): Nearly one in seven people worldwide, an estimated 1.1 billion individuals as of 2021, are living with a mental disorder, according to World Health Organization data, with anxiety and depressive disorders standing out as the most widespread conditions.
The WHO defines a mental disorder as a clinically significant disturbance in a person’s cognition, emotional regulation or behaviour that typically causes distress or impairs important areas of daily functioning, and notes that while effective prevention and treatment methods exist, most affected people still cannot access proper care, often facing stigma, discrimination and violations of their basic rights alongside their condition.
Anxiety disorders alone affected 359 million people in 2021, including 72 million children and adolescents, marked by excessive fear and worry severe enough to disrupt daily life. The category spans several distinct conditions, including generalized anxiety disorder, panic disorder, social anxiety disorder and separation anxiety disorder, and while symptoms vary, psychological treatment has proven effective across these forms, with medication considered depending on a person’s age and the severity of their condition.
Depression represents an even larger share of the global burden, with 280 million people affected in 2019, including 23 million children and adolescents; the condition goes beyond ordinary mood fluctuations, requiring a depressed mood or loss of interest in activities nearly every day for at least two weeks alongside symptoms such as poor concentration, feelings of guilt, disrupted sleep or thoughts of death, and it carries an elevated suicide risk despite the availability of effective psychological and, where appropriate, medical treatment.
Bipolar disorder affected 37 million people globally in 2021, including 3.8 million adolescents aged 10 to 19, and is characterised by alternating depressive episodes and periods of manic symptoms such as euphoria, racing thoughts or impulsive behaviour, again carrying increased suicide risk but responding to treatment that combines psychoeducation, stress reduction, social support and medication.
Post-traumatic stress disorder, which can develop after exposure to extremely threatening or horrific events, involves intrusive memories or flashbacks, avoidance of trauma-related reminders, and a persistent sense of current threat lasting at least several weeks, though effective psychological treatment is available for it as well.
Schizophrenia affects roughly 23 million people worldwide, or about one in every 345 people, and is associated with a life expectancy nine years shorter than the general population, alongside symptoms such as persistent delusions, hallucinations, disorganised thinking and behaviour, and cognitive difficulties; treatment options including medication, psychoeducation, family interventions and psychosocial rehabilitation can nonetheless improve outcomes.
Eating disorders, including anorexia nervosa and bulimia nervosa, affected 16 million people in 2021, among them nearly 3.4 million children and adolescents, involving disordered eating patterns and significant concerns around body weight and shape that carry serious health risks; anorexia in particular is linked to premature death from medical complications or suicide, while bulimia raises the risk of substance use and further health complications, though family-based treatment and cognitive-based therapy have both shown effectiveness.
Disruptive behaviour and dissocial disorders, including conduct disorder and oppositional defiant disorder, affected 41 million people, mostly with onset in childhood, and involve persistent defiance or behaviour that violates others’ rights or age-appropriate norms; cognitive problem-solving and social skills training, often involving parents, caregivers and teachers, have proven effective in addressing them.
Neurodevelopmental disorders, a category that includes autism spectrum disorder, ADHD and disorders of intellectual development, involve difficulties in acquiring intellectual, motor, language or social skills during development, with psychosocial interventions, behavioural therapy, and occupational or speech therapy offering effective support, alongside medication in certain cases.
Across all these conditions, the WHO points to a mix of individual, family, community and structural factors, including poverty, violence, disability and inequality, that can heighten risk, while noting that most people remain resilient despite exposure to such circumstances.
Also Read: Brazil HIV Advocates Warned Early on Aid Funding Cuts
The organisation says health systems globally remain significantly under-resourced relative to need, with only 29 percent of people experiencing psychosis and just a third of people with depression receiving formal mental health care, underscoring a treatment gap that persists worldwide alongside a shortage of social support for relationships, education, employment and housing that people with mental disorders often also require.
In response, the WHO‘s Comprehensive Mental Health Action Plan for 2013 to 2030 sets out to strengthen leadership and governance on mental health, expand community-based care services, advance prevention strategies, and improve information systems and research.
Its Mental Health Gap Action Programme complements this by equipping non-specialist health workers in resource-limited settings with evidence-based tools and training, including the mhGAP Intervention Guide, to expand assessment and treatment capacity for mental disorders at all levels of care.
Managing Editor at Global News Pakistan (GNP), with a Bachelor's degree in International Relations from Riphah International University, graduated with a Gold Medal. Reach out at sabahtareengnp@gmail.com





